Trials / Completed
CompletedNCT06309394
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
An Open-Label Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Incyte Corporation · Industry
- Sex
- Male
- Age
- 35 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to assess the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of \[14C\]INCB099280 in Healthy Male Participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INCB099280 | INCB099280 will be administered orally, followed approximately 10 minutes later by an oral dose solution of radiolabeled INCB099280. |
Timeline
- Start date
- 2024-05-15
- Primary completion
- 2024-06-04
- Completion
- 2024-06-04
- First posted
- 2024-03-13
- Last updated
- 2025-09-11
- Results posted
- 2025-09-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06309394. Inclusion in this directory is not an endorsement.